Fig. 1

Juvenile Idiopathic Arthritis Disease Activity Over Time in Response to Treatment. Patient started treatment with subcutaneous (SC) methotrexate (MTX) and prednisolone at time 0 months. Disease activity at point-of-care was assessed via the 10-joint clinical Juvenile Arthritis Disease Activity Score (cJADAS-10) (range 0–30, 30 represents most severe arthritis) and followed post-diagnosis in response to treatment. Changes in treatment regimen over time are annotated in graph